Welcome to your Wednesday morning round-up of stories in today’s edition of The Legal Intelligencer. All of the links below will take you directly to today’s stories, or you can head straight over to The Legal’s homepage. (Some stories may require registration or a paid subscription.)
The top story this morning is an Eastern District judge certifying a class of third-party purchasers who allege that GlaxoSmithKline filed “sham” citizen petitions with the Food and Drug Administration that kept generic versions of its nasal spray Flonase off the market for two years. As reporter Saranac Hale Spencer writes, the class was narrowed to only those who purchased the generic equivalent after it became available and those who purchased Flonase in one of four states.
Below the fold on Page 1, reporter Amaris Elliott-Engel writes that Obermayer Rebmann is arguing in support of its cross-claims against former partner Jeffrey B. Rotwitt regarding the legal malpractice lawsuit over a new family courthouse. The firm says that Rotwitt acted outside of his written partnership agreement.
In more Regional News on Page 3, Saranac Hale Spencer writes that an instruction to a federal jury to consider “mixed motivations” in the beating death of a Hispanic man was proper, the Third Circuit has ruled.
In an Immigration Law column on Page 5, William A. Stock writes about whether ensuring compliance is also discouraging international students.
This week’s GC Mid-Atlantic is on Page 7, discussing why advertisements may be dangerous to your company’s wealth.
If you have questions or comments about any of today's stories, or our coverage as a whole, we invite you to e-mail any of the reporters directly. We hope you'll enjoy today's Legal.